Prostate Cancer Coverage from Every Angle

Recent News

ASTRO 2022: Assessing Sexual Dysfunction After Brachytherapy for Genitourinary Cancers
ASTRO 2022: Sequencing of Short-Term Androgen-Deprivation Therapy With Radiotherapy for Prostate Cancer
ASTRO 2022: Salvage Radiotherapy Plus Enzalutamide for High-Risk Prostate Cancer After Prostatectomy
SITC 2022: Phase II Study of Vudalimab for Metastatic Castration-Resistant Prostate Cancer
ASTRO 2022: Hypofractionated Radiotherapy for High-Risk Prostate Cancer
ASTRO 2022: Using 24-Gene Score to Predict Outcomes With Salvage Radiotherapy After Radical Prostatectomy
ASTRO 2022: Is There a Correlation Between PSA Screening and Subsequent Metastatic Prostate Cancer?
ASTRO 2022: Combining Hormone Therapy and Metastasis-Directed Radiotherapy for Advanced Prostate Cancer
ASTRO 2022: Multimodal Deep Learning Versus NCCN Risk Stratification of Prostate Cancer
ASTRO 2022: PSMA PET/CT and Its Impact on Prostate Cancer Salvage Radiation Therapy Management
Targeted Imaging With PSMA Tracer May Alter Treatment Plans for Some Patients With Prostate Cancer
Oligometastatic Prostate Cancer: Do Genomic Alterations Have Prognostic Value?
BET Inhibitor Under Study in Metastatic Castration-Resistant Prostate Cancer
ASCO Quality 2022: An Education Initiative That Aims to Improve Equity in Prostate Cancer Screening
Genomic Classifiers as Prognostic Factors for Androgen-Deprivation Therapy for Advanced Prostate Cancer
Targeting Myeloid Chemotaxis in Resistant Metastatic Prostate Cancer
ASCO Quality 2022: Tailored Self-Managed Care for Survivors of Prostate Cancer
Biomarker Analysis From PROpel Trial of Abiraterone Plus Olaparib in Advanced Prostate Cancer
African Ancestry and Genetic Variants in Prostate Tumors
ESMO 2022: Pembrolizumab Plus Olaparib Under Study in Metastatic Castration-Resistant Prostate Cancer
ESMO 2022: Adding Hormonal Therapy to the Treatment Mix in Biochemically Relapsed Prostate Cancer
ESMO 2022: Inhibitor of CYP11A Under Study in Metastatic Castration-Resistant Prostate Cancer
Group Exercise for Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
ESMO 2022: Dosing Adjustments With Cabazitaxel in Older Patients With Prostate Cancer
ESMO 2022: Using 8-Month PSA Values From PEACE-1 to Predict Prostate Cancer Survival
Assessing Genetic Risk in Primary Care May Lead to Earlier Diagnosis for Patients at Risk for Prostate Cancer
Can the Corticosteroid Betamethasone Improve Outcomes With Radiation Therapy for Prostate Cancer?
Using Virtual Reality Models to Improve Surgical Decision-Making in Prostate Cancer
FDA Approves Darolutamide Combination for Metastatic Hormone-Sensitive Prostate Cancer
Genetic Evaluation of Castration-Resistant Prostate Cancer: Focus on CDK6 Expression
FDA Grants Priority Review to Olaparib-Based Combination for Metastatic Castration-Resistant Prostate Cancer
Randomized Trial to Focus on Lifestyle Changes During Radiotherapy for Prostate Cancer
Genomic Studies Offer Insight Into Progression of Prostate Cancer After Hormonal Therapy
Digital Health Coaching for Patients With Prostate Cancer: Findings of a Pilot Study
Combining Tyrosine Kinase and PD-L1 Inhibitors to Treat Metastatic Prostate Cancer
Using a Multimodal Artificial Intelligence System to Personalize Therapy for Prostate Cancer
Are LHRH Antagonists Indicated for Patients With Prostate Cancer at High Cardiovascular Risk?
What Can Be Learned From ctDNA About Treatment-Resistant Prostate Cancer? Researchers Say a Lot

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.